Viewing Study NCT07245069


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2025-12-25 @ 8:24 PM
Study NCT ID: NCT07245069
Status: RECRUITING
Last Update Posted: 2025-11-24
First Post: 2025-11-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients
Sponsor: University Medical Centre Ljubljana
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-02-01
Start Date Type: ACTUAL
Primary Completion Date: 2028-11
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-02
Completion Date Type: ESTIMATED
First Submit Date: 2025-11-17
First Submit QC Date: None
Study First Post Date: 2025-11-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-17
Last Update Post Date: 2025-11-24
Last Update Post Date Type: ESTIMATED